ActiGraph Launches ActiLife Mobile App
ActiGraph, a leading provider of objective patient monitoring solutions for the global research community, today announced the release of a new mobile app for researchers. The iOS compatible ActiLife Mobile app supports in-field communication with the company’s newest generation of wireless-enabled physical activity and sleep/wake monitoring devices, allowing researchers to initiate data capture and view real-time summary data and operating status reports from active devices in the field using an iPhone or iPad.
ActiLife Mobile includes three distinct areas of functionality that offer researchers more flexibility along with an added measure of security against errors and data loss.
Initialization: ActiLife Mobile allows users to configure and initiate data collection for multiple wireless ActiGraph devices from a mobile device. The ability to perform in-field device initializations streamlines project workflow and helps to prevent deployment delays when unforeseen issues arise.
Real-time Summary Data: ActiLife Mobile allows users to perform burst downloads of active wireless devices, providing real-time daily and cumulative statistics on wear time, energy expenditure, steps taken and activity intensity. Researchers are able to quickly assess protocol adherence and intervene as needed.
Device Management: ActiLife Mobile users have the ability to monitor the operating status of active devices, including battery voltage, data collection status, sample rate and amount of recorded data. This critical feature allows the researcher to preemptively identify and correct any issue that may compromise the integrity of a data set.
“ActiLife Mobile was designed specifically to make the researcher’s job easier and more effective by giving them the flexibility to perform many of their tasks outside the lab and without being tethered to a PC workstation.” said Jeremy Wyatt, ActiGraph’s Vice President of Software Engineering. “Perhaps even more important however is the ability to use a mobile device to monitor subject behavior and compliance during data collection. This adds a dynamic element to the study and enables the research team to implement changes in protocol based on real-time information, ultimately saving time and money.”
The ActiLife Mobile iOS app is now available for download in the Apple App Store.
More information about ActiGraph’s wireless and mobile patient monitoring solutions can be found at http://www.actigraphcorp.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
